NCT06734429

Brief Summary

Retrospective monocentric study of the outcomes of patients with neurogenic bladder who had a urinary artificial sphincter before the age of 18 years old. Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

December 11, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

Urinary Artificial SphincterNeurogenic BladderChildOutcomesRetrospective Study

Outcome Measures

Primary Outcomes (2)

  • Number of participants with urinary sphincter incomptetence

    Participants with urinary incontinence caused by urinary sphincter incomptetence

    Before surgery

  • Impact of urinary artificial sphincter on the participants' incontinence

    Three outcomes are possible: the participant is continent (with or without a few leaks), the participant is continent with catheterization, the patient is incontinent.

    Through study completion, an average of 2 years

Secondary Outcomes (4)

  • Impact of bladder augmentation on participants' incontinence

    Through study completion, an average of 2 years

  • Impact of Mitrofanoff procedure on participants' incontinence

    Through study completion, an average of 2 years

  • Impact of bladder neck surgery on participants' incontinence

    Through study completion, an average of 2 years

  • Last follow-up

    Through study completion, an average of 2 years]

Study Arms (1)

Urinary Artificial Sphincter (UAS) in Children

Patients aged under 18 years old with UAS

Other: Urinary Artificial Sphincter

Interventions

Urinary Artificial Sphincter is a device used for patients with urethral sphincter incompetence

Urinary Artificial Sphincter (UAS) in Children

Eligibility Criteria

Age0 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients younger than 18 years old who have neurogenic bladders

You may qualify if:

  • Patients who were younger than 18 years old when they had an urinary artificial sphincter

You may not qualify if:

  • Patients who were 18 years old or older when they had an urinary artificial sphincter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Clermont-Ferrand

Clermont-Ferrand, Auvergne, 63003, France

Location

Related Publications (1)

  • Delgado-Miguel C, Munoz-Serrano A, Amesty V, Rivas S, Lobato R, Martinez-Urrutia MJ, Lopez-Pereira P. Artificial urinary sphincter in congenital neuropathic bladder: Very long-term outcomes. Int J Urol. 2022 Jul;29(7):692-697. doi: 10.1111/iju.14874. Epub 2022 Mar 26.

    PMID: 35340070BACKGROUND

MeSH Terms

Conditions

Urinary Bladder, NeurogenicSpinal Dysraphism

Interventions

Urinary Sphincter, Artificial

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeural Tube DefectsNervous System MalformationsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and SuppliesArtificial OrgansSurgical Equipment

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

December 11, 2024

First Posted

December 16, 2024

Study Start

November 20, 2022

Primary Completion

January 31, 2023

Study Completion

January 31, 2023

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

In the name of anonymization the investigators won't share individual participant data

Locations